440 related articles for article (PubMed ID: 25839704)
21. Impact of preoperative radiation on survival of patients with T3N0 >7-cm non-small cell lung cancers treated with anatomic resection using the Surveillance, Epidemiology, and End Results database.
Moreno AC; Morgensztern D; Yu JB; Boffa DJ; Decker RH; Detterbeck FC; Kim AW
J Surg Res; 2013 Sep; 184(1):10-8. PubMed ID: 23583079
[TBL] [Abstract][Full Text] [Related]
22. Cancer of the head and neck region in solid organ transplant recipients.
Rabinovics N; Mizrachi A; Hadar T; Ad-El D; Feinmesser R; Guttman D; Shpitzer T; Bachar G
Head Neck; 2014 Feb; 36(2):181-6. PubMed ID: 23554129
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
[TBL] [Abstract][Full Text] [Related]
24. Five-year survival does not equal cure in non-small cell lung cancer: a Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10- to 18-year survival.
Hubbard MO; Fu P; Margevicius S; Dowlati A; Linden PA
J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1307-13. PubMed ID: 22361247
[TBL] [Abstract][Full Text] [Related]
25. Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer.
Davis KL; Goyal RK; Able SL; Brown J; Li L; Kaye JA
Lung Cancer; 2015 Feb; 87(2):176-85. PubMed ID: 25532680
[TBL] [Abstract][Full Text] [Related]
26. CDKN2A (p16) promoter hypermethylation influences the outcome in young lung cancer patients.
Bradly DP; Gattuso P; Pool M; Basu S; Liptay M; Bonomi P; Buckingham L
Diagn Mol Pathol; 2012 Dec; 21(4):207-13. PubMed ID: 23111194
[TBL] [Abstract][Full Text] [Related]
27. Characteristics of thoracic malignancies that occur after solid-organ transplantation.
Génébès C; Brouchet L; Kamar N; Lepage B; Prévot G; Rostaing L; Didier A; Mazières J
J Thorac Oncol; 2010 Nov; 5(11):1789-95. PubMed ID: 20975378
[TBL] [Abstract][Full Text] [Related]
28. Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based study.
Rengan R; Mitra N; Liao K; Armstrong K; Vachani A
Lancet Oncol; 2012 Dec; 13(12):1203-9. PubMed ID: 23164952
[TBL] [Abstract][Full Text] [Related]
29. Prostate Cancer Outcomes Following Solid-Organ Transplantation: A SEER-Medicare Analysis.
Liauw SL; Ham SA; Das LC; Rudra S; Packiam VT; Koshy M; Weichselbaum RR; Becker YT; Bodzin AS; Eggener SE
J Natl Cancer Inst; 2020 Aug; 112(8):847-854. PubMed ID: 31728517
[TBL] [Abstract][Full Text] [Related]
30. Association of HLA Antigen Mismatch With Risk of Developing Skin Cancer After Solid-Organ Transplant.
Gao Y; Twigg AR; Hirose R; Roll GR; Nowacki AS; Maytin EV; Vidimos AT; Rajalingam R; Arron ST
JAMA Dermatol; 2019 Mar; 155(3):307-314. PubMed ID: 30673077
[TBL] [Abstract][Full Text] [Related]
31. Risk of merkel cell carcinoma after solid organ transplantation.
Clarke CA; Robbins HA; Tatalovich Z; Lynch CF; Pawlish KS; Finch JL; Hernandez BY; Fraumeni JF; Madeleine MM; Engels EA
J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25575645
[TBL] [Abstract][Full Text] [Related]
32. Worldwide thoracic organ transplantation: a report from the UNOS/ISHLT International Registry for Thoracic Organ Transplantation.
Bennett LE; Keck BM; Daily OP; Novick RJ; Hosenpud JD
Clin Transpl; 2000; ():31-44. PubMed ID: 11512324
[TBL] [Abstract][Full Text] [Related]
33. Population-based estimates of survival benefit associated with combined modality therapy in elderly patients with locally advanced non-small cell lung cancer.
Davidoff AJ; Gardner JF; Seal B; Edelman MJ
J Thorac Oncol; 2011 May; 6(5):934-41. PubMed ID: 21372743
[TBL] [Abstract][Full Text] [Related]
34. Effect of age on survival of clinical stage I non-small-cell lung cancer.
Sigel K; Bonomi M; Packer S; Wisnivesky J
Ann Surg Oncol; 2009 Jul; 16(7):1912-7. PubMed ID: 19408051
[TBL] [Abstract][Full Text] [Related]
35. Sex-associated differences in non-small cell lung cancer in the new era: is gender an independent prognostic factor?
Hsu LH; Chu NM; Liu CC; Tsai SY; You DL; Ko JS; Lu MC; Feng AC
Lung Cancer; 2009 Nov; 66(2):262-7. PubMed ID: 19299032
[TBL] [Abstract][Full Text] [Related]
36. Solid tumors after heart transplantation: lethality of lung cancer.
Pham SM; Kormos RL; Landreneau RJ; Kawai A; Gonzalez-Cancel I; Hardesty RL; Hattler BG; Griffith BP
Ann Thorac Surg; 1995 Dec; 60(6):1623-6. PubMed ID: 8787454
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors and nomogram for cancer-specific death in non small cell lung cancer with malignant pericardial effusion.
Hu ZG; Hu K; Li WX; Zeng FJ
PLoS One; 2019; 14(5):e0217007. PubMed ID: 31095610
[TBL] [Abstract][Full Text] [Related]
38. Non-small-cell lung cancer after breast cancer: a population-based study of clinicopathologic characteristics and survival outcomes in 3529 women.
Milano MT; Strawderman RL; Venigalla S; Ng K; Travis LB
J Thorac Oncol; 2014 Aug; 9(8):1081-90. PubMed ID: 25157761
[TBL] [Abstract][Full Text] [Related]
39. Longitudinal dose and type of immunosuppression in a national cohort of Australian liver, heart, and lung transplant recipients, 1984-2006.
Na R; Laaksonen MA; Grulich AE; Webster AC; Meagher NS; McCaughan GW; Keogh AM; Vajdic CM
Clin Transplant; 2015 Nov; 29(11):978-90. PubMed ID: 26278925
[TBL] [Abstract][Full Text] [Related]
40. De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population.
Miao Y; Everly JJ; Gross TG; Tevar AD; First MR; Alloway RR; Woodle ES
Transplantation; 2009 May; 87(9):1347-59. PubMed ID: 19424035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
